Federal Register / Vol. 76, No. 41 / Wednesday, March 2, 2011 / Notices 11499 

TABLE 1—ESTIMATES OF BURDEN HOURS OVER THREE YEARS (GENERIC SUBMISSION) 

Type of respondents Number of respondents 

Frequency of 

response 

Average time 

per response 

(minutes/hour) 

Annual hour 

burden 

Managers, Executives, and Directors .............................................................. 4,000 1 20/60 (0.33) 1,333 

Request for Comments: Written 

comments and/or suggestions from the 

public and affected agencies should 

address one or more of the following 

points: (1) Evaluate whether the 

proposed collection of information is 

necessary for the proper performance of 

the function of the agency, including 

whether the information will have 

practical utility; (2) Evaluate the 

accuracy of the agency’s estimate of the 

burden of the proposed collection of 

information, including the validity of 

the methodology and assumptions used; 

(3) Enhance the quality, utility, and 

clarity of the information to be 

collected; and (4) Minimize the burden 

of the collection of information on those 

who are to respond, including the use 

of appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms of 

information technology. 

Direct Comments to OMB: Written 

comments and/or suggestions regarding 

the item(s) contained in this notice, 

especially regarding the estimated 

public burden and associated response 

time, should be directed to the 

Attention: NIH Desk Officer, Office of 

Management and Budget, at 

OIRA_submission@omb.eop.gov or by 

fax to 202–395–6974. To request more 

information on the proposed project or 

to obtain a copy of the data collection 

plans and instruments, contact John D. 

Hewes, Ph.D., Technology Transfer 

Specialist, Technology Transfer Center, 

National Cancer Institute, 6120 

Executive Blvd., MSC 7181, Suite 450, 

Rockville, MD 20852 or call non-tollfree number 301–435–3121 or e-mail 

your request, including your address to: 

hewesj@mail.nih.gov. 

Comments Due Date: Comments 

regarding this information collection are 

best assured of having their full effect if 

received within 30 days of the date of 

this publication. 

Dated: February 17, 2011. 

Vivian Horovitch-Kelley, 

NCI Project Clearance Liaison Office, 

National Institutes of Health. 

[FR Doc. 2011–4600 Filed 3–1–11; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the Board 

of Scientific Counselors, NIDDK. 

The meeting will be closed to the 

public as indicated below in accordance 

with the provisions set forth in section 

552b(c)(6), Title 5 U.S.C., as amended 

for the review, discussion, and 

evaluation of individual intramural 

programs and projects conducted by the 

National Institute of Diabetes and 

Digestive and Kidney Diseases, 

including consideration of personnel 

qualifications and performance, and the 

competence of individual investigators, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Board of Scientific 

Counselors, NIDDK. 

Date: April 7–8, 2011. 

Time: April 7, 2011, 8:30 a.m. to 3:15 p.m. 

Agenda: To review and evaluate personal 

qualifications and performance, and 

competence of individual investigators. 

Place: National Institutes of Health, 

Building 10, 10 Center Drive, Conference 

Room 2C116, Bethesda, MD 20892. 

Time: April 8, 2011, 8:30 a.m. to 3:30 p.m. 

Agenda: To review and evaluate to review 

and evaluate personal qualifications and 

performance, and competence of individual 

investigators. 

Place: National Institutes of Health, 

Building 10, 10 Center Drive, Conference 

Room 2C116, Bethesda, MD 20892. 

Contact Person: 

IRA W. LEVIN, PhD, Director, Division of 

Intramural Research, National Institute of 

Diabetes and Digestive, and Kidney Diseases, 

NIH, Bethesda, MD 20892, 301–496–6844. 

iwl@helix.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 

Dated: February 24, 2011. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2011–4626 Filed 3–1–11; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center on Minority and Health 

Disparities; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable materials, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Center on 

Minority Health and Health Disparities 

Special Emphasis Panel; 2011 LRP Panel 1. 

Date: March 18, 2011. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Two 

Democracy Plaza, 6707 Democracy 

Boulevard, Bethesda, MD 20892, (Virtual 

Meeting) 

Contact Person: Maryline Laude-Sharp, 

PhD, Scientific Review Officer, National 

Institute on Minority Health and Health 

Disparities, 6707 Democracy Boulevard, 

Suite 800, Bethesda, MD 20892, (301) 451– 

9536, mlaudesharp@mail.nih.gov. 


emcdonald on DSK2BSOYB1PROD with NOTICES